Digoxigenin

Digoxigenin

SCHEMBL11077489

C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2CC(O)[C@]2(C)[C@@H](C3=CC(=O)OC3)CC[C@]12O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 6/20 1.00
▸ PAX8 Q06710 4/20 1.00
▸ LMNA P02545 4/20 1.00
▸ SMN1; SMN2 Q16637 4/20 1.00
▸ RAB9A P51151 4/20 1.00
▸ HIF1A Q16665 3/20 1.00
▸ NPC1 O15118 3/20 1.00
▸ CYP2C19 P33261 2/20 1.00
▸ HSD17B10 Q99714 1/20 1.00
▸ SLCO4C1 Q6ZQN7 1/20 1.00
▸ ATP1A1 P05023 9/20 0.74
▸ ATP1B1 P05026 9/20 0.74
▸ ATP1B2 P14415 9/20 0.74
▸ ATP1A2 P50993 9/20 0.74
▸ ATP1B3 P54709 9/20 0.74
▸ TSHR P16473 2/20 0.74
▸ ATP1A3 P13637 2/20 0.74
▸ FXYD2 P54710 2/20 0.74
▸ ATP1A4 Q13733 2/20 0.74
▸ CYP3A4 P08684 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Digoxigenin SCHEMBL13337910 1.00 TP53 (1.00) TP53PAX8LMNASMN1; SMN2RAB9A
Digoxigenin SCHEMBL8816469 1.00 TP53 (1.00) TP53PAX8LMNASMN1; SMN2RAB9A
Digoxigenin SCHEMBL4994463 1.00 TP53 (1.00) TP53PAX8LMNASMN1; SMN2RAB9A
Digoxigenin SCHEMBL21105 1.00 TP53 (1.00) TP53PAX8LMNASMN1; SMN2RAB9A
Digoxigenin SCHEMBL24012132 1.00 TP53 (1.00) TP53PAX8LMNASMN1; SMN2RAB9A
Digoxigenin SCHEMBL13362000 1.00 TP53 (1.00) TP53PAX8LMNASMN1; SMN2RAB9A
Digoxigenin SCHEMBL23827178 1.00 TP53 (1.00) TP53PAX8LMNASMN1; SMN2RAB9A
Digoxigenin SCHEMBL12841138 1.00 TP53 (1.00) TP53PAX8LMNASMN1; SMN2RAB9A
Digoxigenin SCHEMBL8816474 1.00 TP53 (1.00) TP53PAX8LMNASMN1; SMN2RAB9A
Digoxigenin SCHEMBL29477343 1.00 TP53 (1.00) TP53PAX8LMNASMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190350923-A1 NATURAL COMPOUNDS AND FIBROSIS MEDIZINISCHE HOCHSCHULE HANNOVER (MHH) (DE) 2019-11-21 — — US disclosed
US-4436828-A Reactive asymmetrical dicarboxylic acid esters and reagents for the investigation of cardiac glycosides BOEHRINGER MANNHEIM GMBH (DE) 1984-03-13 — — US disclosed
US-4282151-A Reactive asymmetrical dicarboxylic acid esters and reagents for the investigation of cardiac glycosides BOEHRINGER MANNHEIM GMBH (DE) 1981-08-04 — — US disclosed
US-4133949-A Dicarboxylic acid esters of cardiac glycosides BOEHRINGER MANNHEIM GMBH (DE) 1979-01-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190350923-A1 NATURAL COMPOUNDS AND FIBROSIS MMP1, MKI67, HES1 TP53 1768/4885PAX8 568/4885LMNA 1318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback